Trial intelligence / Profile preview

Comparison of autologous platelet-rich plasma (PRP) with protokine (ASC) for repeated implantation failure

IRCT20250924067348N1Phase 2Recruiting

Sponsor
Hamadan University of Medical Sciences
Start
Nov 2025
Countries
1
01

Overview

Phase 2 trial of platelet-rich plasma in female infertility and Recurrent Implantation Failure (RIF) (2 arms), sponsored by Hamadan University of Medical Sciences. Started Nov 2025; status: recruiting.

02

Drugs

platelet-rich plasma
03

Conditions

female infertilityRecurrent Implantation Failure (RIF)

Beyond the preview

Go deeper on IRCT20250924067348N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20250924067348N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call